To determine the effect of restoring Tryp levels in the plasma of tumor-bearing mice, we administrated the IDO inhibitor 1-MT, previously proven to have no toxicity [23,24] and we studied signs of cachexia and inflammation. This evidence concerns the gene IDO1 and neoplasm.